Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Pinheiro NM
,
Miranda CJ
,
Perini A
,
Câmara NO
,
Costa SK
,
Alonso-Vale MI
,
Caperuto LC
,
Tibério IF
,
Prado MA
,
Martins MA
,
Prado VF
,
Prado CM
.
???displayArticle.abstract???
Acetylcholine (ACh) plays a crucial role in physiological responses of both the central and the peripheral nervous system. Moreover, ACh was described as an anti-inflammatory mediator involved in the suppression of exacerbated innate response and cytokine release in various organs. However, the specific contributions of endogenous release ACh for inflammatory responses in the lung are not well understood. To address this question we have used mice with reduced levels of the vesicular acetylcholine transporter (VAChT), a protein required for ACh storage in secretory vesicles. VAChT deficiency induced airway inflammation with enhanced TNF-α and IL-4 content, but not IL-6, IL-13 and IL-10 quantified by ELISA. Mice with decreased levels of VAChT presented increased collagen and elastic fibers deposition in airway walls which was consistent with an increase in inflammatory cells positive to MMP-9 and TIMP-1 in the lung. In vivo lung function evaluation showed airway hyperresponsiveness to methacholine in mutant mice. The expression of nuclear factor-kappa B (p65-NF-kB) in lung of VAChT-deficient mice were higher than in wild-type mice, whereas a decreased expression of janus-kinase 2 (JAK2) was observed in the lung of mutant animals. Our findings show the first evidence that cholinergic deficiency impaired lung function and produce local inflammation. Our data supports the notion that cholinergic system modulates airway inflammation by modulation of JAK2 and NF-kB pathway. We proposed that intact cholinergic pathway is necessary to maintain the lung homeostasis.
???displayArticle.pubmedLink???
25816137
???displayArticle.pmcLink???PMC4376856 ???displayArticle.link???PLoS One
Fig 1. Protein content and mRNA levels of VAChT. A and B.VAChT mRNA expression (A) measured by real-time PCR (6–8 mice per group) and protein content (B) quantified by Western Blot (3 mice per group) in spinal cord from wild-type and VAChT-KDHOM (mutant). C and D. VAChT mRNA expression (C) measured by real-time PCR (6–8 per group) and protein content (D) quantified by Western blot (6–8 mice per group) in lung from wild-type and VAChT-KDHOM (mutant). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a housekeeping for gene expression analysis (A and C) and β-actin was used as protein loading control for Western Blot (B and D). Both were presented as a percentage of WT. The gels (B and D) is representative of results that were obtained in an experiment that was repeated two times. *p<0.05 vs wild-type mice. E and F: Body weight in g (E) in wild-type and mutant mice and the time in wire hang test performed before all measurements in seconds (F). E and F represent data of 8–14 animals per group. Data area expressed as means ± SEM. *P<0.001 vs. wild-type mice.
Fig 2. VAChT deficiency did not affect other cholinergic component in lung.Muscarinic receptor 2 (M2), high-affinity choline transporter (CHT1), α7 nicotinic acetylcholine receptor (α7nAChR) and Acetylcholinesterase protein expression was analyzed by Western Blot. The gel is representative of results that were obtained in an experiment that was repeated two times. The graphs represent the values normalized by β-actin.
Fig 3. VAChT deficiency increased peribronchial edema and pulmonary inflammation.A. Peribronchial edema evaluated around airways. Lung were fixed in 10% formalin and embedded in paraffin before sections were cut and stained with hematoxylyn and eosin. VAChT KD-HOM increased peribronchovascular edema (*p<0.001 vs wild-type mice). B to D. Representative photomicrographs illustrating the peribronchial edema and cellular infiltration around airways obtained from a VAChT mutant mice (C and D) compared to wild-type (B). E. Amount of total protein measured in bronchoalveolar lavage (BALF) (n = 7–8 per group, *p<0.01 vs wild-type mice). F. Mean and standard error of macrophages, lymphocytes, eosinophils and neutrophils counted in bronchial alveolar lavage fluid (BALF) (n = 7–8 per group, *P<0.05 vs wild-type mice). G and H represent peribronchovascular mononuclear (*p<0.05 vs wild-type mice) and polymorphonuclear cells, respectively, evaluated around airways.
Fig 4. VAChT-deficient mice presented high levels of pro-inflammatory cytokines.Data are expressed as mean ±SEM of five to eight mice per group. Cytokines was measured by ELISA in lung homogenate. Mutant mice (VAChT KD-HOM) presented high values of TNF-α and IL-4 compared to wild-type animals. *p<0.05 vs wild-type mice.
Fig 5. VAChT deficiency increased p65-NF-kB expression in lung.Subunit p65-NF-kB protein expression was measured by western blot (A). The gel is representative of results that were obtained in an experiment that was repeated two times. The graphs represent the values normalized by β-actin (n = 5 per group). *p<0.05 vs wild-type group. Number of inflammatory cells positive to p65-NF-kB (B) from 6–8 animals per group was visualized by immunohistochemistry in paraffin embedded section. Representative photomicrographs used to detect NF-kB (Panels C to F) showed a stronger stain in mutant mice (E and F) compared to wild-type mice (C and D). Arrows indicate positive cells around airway wall. *p<0.001 vs wild-type group.
Fig 6. VAChT deficiency reduced JAK-2 expression in lung.Janus kinase 2 (JAK-2) (A), signal transducer and activator of transcription 3 (STAT3) (B) and phosphorylated STAT3 (C) and suppressor of cytokine signaling 3 (SOCS-3) (D) protein expression was measured by Western Blot. The gel is representative of results that were obtained in an experiment that was repeated two times. The graphs represent the values normalized by β-actin. *p<0.05 vs wild-type group.
Fig 7. VAChT-deficient induced airway remodeling.Data of collagen (A) and elastic fibers content (B) are expressed as mean ±SEM at twelve to fourteen mice per group. It was evaluated in paraffin sections stained with Picro-Sirius and Resorcin-Fuchsin respectively, and it was measured around airways using an image analysis system. Number of inflammatory cells positive to MMP-9 (C) and TIMP-1 (D) from 6–8 animals per group was visualized by immunohistochemistry in paraffin embedded section. Collagen content was enhanced by VAChT deficiency and it can be observed in panels E (wild-type) and H (mutant mice). Representative photomicrographs used to detect MMP-9 (Panels F and I) and TIMP-1 (panels G and J) showed a stronger stain in mutant mice. A and D *p<0.001 vs wild-type group and B and C *p<0.05 vs wild-type group.
Fig 8. Airway hyperresponsiveness in VAChT deficiency animals.Respiratory system elastance (Ers) (A and B) and resistance (Rrs) (C and D) was recorded in wild-type and mutant mice. We performed a dose response curve to methacholine and values were obtained 30 seconds after each infusion (panels B and D). We also analyzed the percentage of maximal responses related to baseline (A and C). Data are expressed as mean and standard error of the 6–8 animals per group. *p<0.05 compared to wild-type.
Araujo,
Extracellular matrix components and regulators in the airway smooth muscle in asthma.
2008, Pubmed
Araujo,
Extracellular matrix components and regulators in the airway smooth muscle in asthma.
2008,
Pubmed
Arvidsson,
Vesicular acetylcholine transporter (VAChT) protein: a novel and unique marker for cholinergic neurons in the central and peripheral nervous systems.
1997,
Pubmed
Borovikova,
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin.
2000,
Pubmed
Caperuto,
Modulation of bone morphogenetic protein-9 expression and processing by insulin, glucose, and glucocorticoids: possible candidate for hepatic insulin-sensitizing substance.
2008,
Pubmed
Catal,
A human monoclonal anti-TNF alpha antibody (adalimumab) reduces airway inflammation and ameliorates lung histology in a murine model of acute asthma.
2015,
Pubmed
Chetta,
Airways remodeling is a distinctive feature of asthma and is related to severity of disease.
1997,
Pubmed
Ganesan,
Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression.
2010,
Pubmed
Greenlee,
Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.
2007,
Pubmed
Guzman,
Elimination of the vesicular acetylcholine transporter in the striatum reveals regulation of behaviour by cholinergic-glutamatergic co-transmission.
2011,
Pubmed
Hantos,
Lung volumes and respiratory mechanics in elastase-induced emphysema in mice.
2008,
Pubmed
Hofer,
Pharmacologic cholinesterase inhibition improves survival in experimental sepsis.
2008,
Pubmed
Ishii,
Muscarinic acetylcholine receptors.
2006,
Pubmed
Karlsen,
Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1beta-mediated toxicity through inhibition of multiple nuclear factor-kappaB-regulated proapoptotic pathways.
2004,
Pubmed
Kawashima,
Critical roles of acetylcholine and the muscarinic and nicotinic acetylcholine receptors in the regulation of immune function.
2012,
Pubmed
Kawashima,
Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function.
2004,
Pubmed
Kox,
Effects of vagus nerve stimulation and vagotomy on systemic and pulmonary inflammation in a two-hit model in rats.
2012,
Pubmed
Kummer,
Non-neuronal cholinergic airway epithelium biology.
2014,
Pubmed
Kummer,
The epithelial cholinergic system of the airways.
2008,
Pubmed
Lara,
Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure.
2010,
Pubmed
Lima,
Quantal release of acetylcholine in mice with reduced levels of the vesicular acetylcholine transporter.
2010,
Pubmed
Lips,
Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium.
2005,
Pubmed
Lips,
Down-regulation of the non-neuronal acetylcholine synthesis and release machinery in acute allergic airway inflammation of rat and mouse.
2007,
Pubmed
Mazzon,
Effect of tumour necrosis factor-alpha receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept.
2008,
Pubmed
Moldoveanu,
Inflammatory mechanisms in the lung.
2009,
Pubmed
Murray,
The JAK-STAT signaling pathway: input and output integration.
2007,
Pubmed
Parrish,
Experimental therapeutic strategies for severe sepsis: mediators and mechanisms.
2008,
Pubmed
Pavlov,
Controlling inflammation: the cholinergic anti-inflammatory pathway.
2006,
Pubmed
Peña,
JAK2 inhibition prevents innate immune responses and rescues animals from sepsis.
2010,
Pubmed
Phipps,
Acute allergen-induced airway remodeling in atopic asthma.
2004,
Pubmed
Postma,
Remodeling in asthma and chronic obstructive pulmonary disease.
2006,
Pubmed
Prado,
Regulation of acetylcholine synthesis and storage.
2002,
Pubmed
Prado,
Effects of nitric oxide synthases in chronic allergic airway inflammation and remodeling.
2006,
Pubmed
Prado,
Regulation of cholinergic activity by the vesicular acetylcholine transporter.
2013,
Pubmed
Prado,
Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition.
2006,
Pubmed
Proskocil,
Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells.
2004,
Pubmed
Qin,
SOCS3 deficiency promotes M1 macrophage polarization and inflammation.
2012,
Pubmed
Racké,
Control by cholinergic mechanisms.
2006,
Pubmed
Rosas-Ballina,
Cholinergic control of inflammation.
2009,
Pubmed
Rosas-Ballina,
Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit.
2011,
Pubmed
Roy,
Cardiomyocyte-secreted acetylcholine is required for maintenance of homeostasis in the heart.
2013,
Pubmed
Sango,
Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis.
1996,
Pubmed
Schelegle,
Vagal afferents contribute to exacerbated airway responses following ozone and allergen challenge.
2012,
Pubmed
Song,
The protective effect of the cholinergic anti-inflammatory pathway against septic shock in rats.
2008,
Pubmed
Su,
Activation of the alpha7 nAChR reduces acid-induced acute lung injury in mice and rats.
2007,
Pubmed
Su,
Requisite role of the cholinergic alpha7 nicotinic acetylcholine receptor pathway in suppressing Gram-negative sepsis-induced acute lung inflammatory injury.
2010,
Pubmed
Toledo,
Flavonone treatment reverses airway inflammation and remodelling in an asthma murine model.
2013,
Pubmed
Verbout,
Atropine pretreatment enhances airway hyperreactivity in antigen-challenged guinea pigs through an eosinophil-dependent mechanism.
2007,
Pubmed
Vieira,
Aerobic exercise decreases chronic allergic lung inflammation and airway remodeling in mice.
2007,
Pubmed
Wang,
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis.
2004,
Pubmed
Wessler,
Dysfunction of the non-neuronal cholinergic system in the airways and blood cells of patients with cystic fibrosis.
2007,
Pubmed
Wessler,
The non-neuronal cholinergic system in humans: expression, function and pathophysiology.
2003,
Pubmed
Yang,
A novel regulator of lung inflammation and immunity: pulmonary parasympathetic inflammatory reflex.
2014,
Pubmed
de Castro,
The vesicular acetylcholine transporter is required for neuromuscular development and function.
2009,
Pubmed
de Jonge,
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway.
2005,
Pubmed
van Westerloo,
The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis.
2005,
Pubmed
